Febuxostat vs Dotinurad: Which Gout Medication Is Right for You?

Febuxostat vs Dotinurad: Two Different Paths to Lower Uric Acid

If your uric acid levels keep climbing despite lifestyle changes, your doctor has probably mentioned urate-lowering therapy. Two medications often come up in that conversation: febuxostat and dotinurad. They both lower uric acid, but they get there through distinctly different routes. Picking the right one starts with understanding how each works.

Think of your body’s uric acid system like plumbing. Febuxostat stops uric acid from being made in the first place, like shutting off the faucet. Dotinurad helps your kidneys flush out uric acid that’s already circulating, like clearing a clogged drain. Same destination, different roads. So which road should you take?

Step One: Find Your Uric Acid Phenotype

Before choosing any medication, you need to know why your uric acid is high. The test that answers this is a 24-hour urine uric acid collection. It measures how much uric acid your kidneys remove over a full day, which tells your doctor whether your body overproduces uric acid or underexcretes it.

Here’s how people with gout roughly break down:

• About 60% are underexcreters, meaning their kidneys don’t clear enough uric acid
• About 10 to 15% are overproducers, making more uric acid than their kidneys can handle
• About 25% have a mix of both problems

If you’re not sure what your numbers mean, our guide to reading your uric acid test results breaks it down in plain language. And if you need to know which tests to ask for, the complete gout lab test guide covers everything your doctor should be ordering.

This phenotype matters because it points toward the right drug class. Underexcreters tend to respond well to dotinurad, which helps the kidneys push out more uric acid. Overproducers typically benefit from febuxostat, which blocks the enzyme that creates uric acid.

When Febuxostat Makes Sense

Febuxostat inhibits xanthine oxidase, the enzyme that converts purines into uric acid. Because it doesn’t rely on kidney function to work, it’s a practical option for people with reduced kidney function. If you’re dealing with kidney disease alongside gout, febuxostat doesn’t require the same dose adjustments that some other urate-lowering drugs do.

You might lean toward febuxostat if you:

• Have reduced kidney function (febuxostat is metabolized mainly by the liver)
• Have a history of kidney stones
• Are already stable on it with good uric acid control
• Are an overproducer based on your 24-hour urine test
• Have cost considerations that make febuxostat more accessible

But febuxostat carries an FDA black box warning for cardiovascular events. If you’ve had a heart attack, stroke, or unstable angina, this deserves a careful conversation with your doctor. You can read more about febuxostat’s cardiovascular safety profile to see what the data actually says.

When Dotinurad Makes Sense

Dotinurad takes a different approach. Instead of stopping production, it blocks a transporter protein called URAT1 in the kidneys. This protein normally pulls uric acid back from urine into your bloodstream. By blocking it, dotinurad lets more uric acid exit through your urine. The concept is straightforward, but it only works if your kidneys are healthy enough to handle the extra load.

Dotinurad may be a better fit if you:

• Have cardiovascular concerns that make febuxostat risky
• Didn’t achieve target uric acid levels on febuxostat
• Experienced elevated liver enzymes on febuxostat (roughly 12.4% of patients do, compared with about 10.8% on dotinurad)
• Are an underexcreter based on your 24-hour urine results

Dotinurad was approved in Japan in 2020 and is now available in several countries. It’s newer than febuxostat, which means there’s less long-term safety data. But the Phase III trial results showed solid uric acid lowering with a tolerable side effect profile.

When Dotinurad Is Off the Table

Several situations rule dotinurad out:

• Severe kidney disease: If your estimated glomerular filtration rate (eGFR) is below 30, dotinurad is contraindicated. Your kidneys can’t safely handle the extra uric acid excretion.
• Kidney stones: If you’ve had kidney stones related to gout, pushing more uric acid through your urinary tract could make things worse.
• Low-dose aspirin: Aspirin interferes with uric acid excretion and can blunt dotinurad’s effect.
• Thiazide diuretics: These common blood pressure medications reduce uric acid excretion. If you take these for high blood pressure alongside gout, talk to your doctor about alternatives.
• Age and pregnancy: Dotinurad is not recommended for anyone under 18 or during pregnancy.

Switching Medications: A Five-Step Process

If you and your doctor decide to switch from febuxostat to dotinurad, the process is straightforward but needs to be done carefully:

1. Confirm your phenotype. Make sure your 24-hour urine test actually shows underexcretion. Switching without this data is like choosing a medication blindfolded.
2. Stop febuxostat and wait 1 to 2 days. This short washout period lets your body clear the previous medication.
3. Start dotinurad at 1 mg per day. This is the standard starting dose. After 4 weeks, your doctor may increase it to 2 mg. The maximum dose is 4 mg per day.
4. Have flare medication on standby. Any change in uric acid levels can trigger a gout attack. Keep colchicine or a nonsteroidal anti-inflammatory drug (NSAID) ready.
5. Recheck at 2 to 4 weeks. Your blood work should include uric acid, liver function, and kidney function to confirm the new medication is working and well tolerated.

For reference on dose equivalency: dotinurad 2 mg is roughly comparable to febuxostat 40 mg in terms of uric acid lowering. But similar uric acid reduction doesn’t mean the drugs work the same way in your body, which is why the switch needs medical supervision.

Five Pitfalls to Avoid

Whether you’re on febuxostat, dotinurad, or switching between them, these mistakes trip people up:

1. Not drinking enough water. Dotinurad pushes uric acid through your kidneys. Aim for about 2,000 ml of water daily to help flush it through and reduce stone risk.
2. Staying on the same dose forever. Your uric acid target may shift as your condition evolves. Doses should be adjusted based on follow-up blood work, not locked in on day one.
3. Stopping on your own. When your numbers look good, it’s tempting to quit. But stopping urate-lowering medication without medical guidance can trigger rebound flares.
4. Skipping regular monitoring. Every 3 months, check your liver and kidney function. Elevated liver enzymes happen with both drugs, and catching them early prevents bigger problems.
5. Starting during a flare. Don’t begin dotinurad or switch medications while you’re in the middle of a gout attack. Wait until the flare settles, then start with anti-inflammatory coverage.

Struggling to stay consistent with your gout medication? You’re not alone. Medication adherence remains one of the biggest challenges in gout care. Understanding why you’re taking a specific drug, and how it matches your body’s uric acid handling, can help you stick with it.

Frequently Asked Questions

Can I take febuxostat and dotinurad at the same time?

Generally, no. These medications lower uric acid through different pathways, but combining them isn’t standard practice. Using both could push uric acid too low and raise the risk of side effects. Your doctor will choose one based on your phenotype and health profile.

How long does dotinurad take to work?

You can expect to see uric acid levels drop within 2 to 4 weeks of starting dotinurad. The full effect typically appears after a dose adjustment to 2 mg or 4 mg. Your doctor will recheck your levels and adjust accordingly.

Is dotinurad safer than febuxostat?

That depends on your health picture. Dotinurad avoids the cardiovascular risk associated with febuxostat’s black box warning, but it carries its own risks for people with kidney disease or kidney stones. Neither drug is universally safer. The right question is which one is safer for you.

What if neither medication works?

If both febuxostat and dotinurad fail to lower your uric acid adequately, other options exist, including allopurinol and other urate-lowering medications. Sometimes the issue is adherence rather than drug failure. Work with your doctor to identify the real problem before switching again.

The Bottom Line

Three things should guide your choice: your uric acid phenotype from a 24-hour urine test, your overall health conditions (especially heart and kidney function), and practical considerations like cost and availability. There’s no universal “best” gout medication. The right one is the one that matches how your body handles uric acid.

Talk to your doctor. Bring your lab results. Ask whether your gout is driven by overproduction or underexcretion. That single answer points you toward the medication most likely to work.

Reviewed by the GoutSavvy Editorial Team